MiR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-Β

Cell Research

Volumn 20, Issue 10, 2010, Pages 1158-1169

  Sun, Wei ^a   Shen, Wenwen ^a   Yang, Shuang ^a   Hu, Fen ^a   Li, Huihui ^a   Zhu, Tian Hui ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

CEBP ; LMO2 L; LMO2 S; miR 142; miR 223; proliferation

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CEBPB PROTEIN, HUMAN; DNA BINDING PROTEIN; ISOPROTEIN; LMO2 PROTEIN, HUMAN; METALLOPROTEIN; MICRORNA; MIRN142 MICRORNA, HUMAN; MIRN223 MICRORNA, HUMAN;

ARTICLE; CELL PROLIFERATION; CELL STRAIN K 562; GENETICS; HEMATOPOIESIS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL PROLIFERATION; DNA-BINDING PROTEINS; HEMATOPOIESIS; HUMANS; K562 CELLS; METALLOPROTEINS; MICRORNAS; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS;

EID: 77957572525     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.134     Document Type: Article

References (43)

1. Yu J, Wang F, Yang GH, et al. Human microRNA clusters: Genomic organization and expression profle in leukemia cell lines. Biochem Biophys Res Commun 2006; 349:59-68.
2. Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23:4051-4060.
3. Cai X, Hagedorn CH, Cullen BR. Human micro-RNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10:1957-1966.
4. Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425:415-419.
5. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432:231-235.
6. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004; 303:95-98.
7. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003; 17:3011-3016.
8. Grishok A, Pasquinelli AE, Conte D, et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 2001; 106:23-34.
9. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001; 293:834-838.
10. Doench JG, Sharp PA. Specifcity of microRNA target selection in translational repression. Genes Dev 2004; 18:504-511.
11. Shivdasani RA. MicroRNAs: regulators of gene expression and cell differentiation. Blood 2006; 108:3646-3653.
12. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303:83-86.
13. Fazi F, Rosa A, Fatica A, et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPal-pha regulates human granulopoiesis. Cell 2005; 123:819-831.
14. Fazi F, Racanicchi S, Zardo G, et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ ETO oncoprotein. Cancer Cell 2007; 12:457-466.
15. Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by mi-croRNA-223. Nature 2008; 451:1125-1129.
16. Yuan JY, Wang F, Yu J, Yang GH, Liu XL, Zhang JW. Mi-croRNA-223 reversibly regulates erythroid and megakaryo-cytic differentiation of K562 cells. J Cell Mol Med 2008; 13:4551-4559.
17. Fukao T, Fukuda Y, Kiga K, et al. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profling. Cell 2007; 129:617-631.
18. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 1998; 273:28545-28548.
19. Xie H, Ye M, Feng R, Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004; 117:663-676.
20. Laiosa CV, Stadtfeld M, Xie H, Andres-Aguayo L, Graf T. Reprogramming of committed T cell progenitors to mac-rophages and dendritic cells by C/EBPa and PU.1 transcription factors, Immunity, 2006, 25, 731-744
21. Royer-Pokora B, Loos Uschi, Ludwig WD, et al. TTG-2 a new gene encoding a cysteine-rich protein with LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14) (p13;q11). Oncogene 1991; 6:1887-1893.
22. Aplan PD, Lombardi DP, Reaman GH, Sather HN, Hammond GD, Kirsch IR. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 1992; 79:1327-1333.
23. Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1:75-87.
24. Ferrando AA, Herblot S, Palomero T, et al. Biallelic transcrip-tional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Blood 2004; 103:1909-1911.
25. Pike-Overzet K, de Ridder D, Weerkamp F, et al. Ectopic retroviral expression of LMO2, but not IL2Rc, blocks human T-cell development. Leukemia 2007; 21:754-763.
26. Yamada Y, Warren AJ, Dobson C, et al. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoi-esis. Proc Natl Acad Sci USA 1998; 95:3890-3895.
27. Yamada Y, Pannell R, Forster A, et al. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci USA 2000; 97:320-324.
28. Warren AJ, Colledge WH, Carlton MB, et al. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for eryth-roid development. Cell 1994; 78:45-57.
29. Larson RC, Fisch P, Larson TA, et al. T cell tumours with disparate phenotype in mice transgenic for Rbtn-2. Oncogene 1994; 9:3675-3681.
30. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302:415-419.
31. McCormack MP, Forster A, Drynan L, Pannell R, Rabbitts TH. The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Mol Cell Biol 2003; 23:9003-9013.
32. Royer-Pokora B, Rogers M, Zhu TH, et al. the TTG-2/RBTN-2 T cell oncogene encodes two alternative transcripts form two promoter: the distal promoter is removed by most 11p13 translocations in acute T cell leukemia's (T-ALL). Oncogene 1995; 10:1353-1360.
33. Zhu T, Qin G, Royer-Pokora B. A novel post-transcriptional splicing form of the acute T cell leukemia proto-oncogene Lmo2. Sci China C Life Sci 2001; 44:561-569.
34. Hammond SM, Crable SC, Anderson KP. Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. Leuk Res 2005; 29:89-97.
35. Landry JR, Kinston S, Knezevic K, Donaldson IJ, Green AR, Göttgens B. Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells. Blood 2005; 106:2680-2687.
36. Wang Q, Zhang M, Wang X, et al. A novel transcript of the LMO2 gene, LMO2-c, is regulated by GATA-1 and PU.1 and encodes an antagonist of LMO2. Leukemia 2007; 21:1015-1025.
37. Wadman I A, Osada H, Grutz G, et al. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J 1997; 16:3145-3157.
38. Nam CH, Rabbitts TH. The role of LMO2 in development and in T cell leukemia after chromosomal translocation or ret-roviral insertion. Mol Ther 2006; 13:15-25.
39. Yuan W, Sun W, Yang S, et al. Down-regulation of microR-NA-142 by proto-oncogene LMO2 and its co-factors. Leukemia 2008; 22:1067-1071.
40. Felli N, Fontana L, Pelosi E, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005; 102:18081-18086.
41. Garzon R, Pichiorri F, Palumbo T, et al. MicroRNA fnger-prints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 2006; 103:5078-5083.
42. Karginov FV, Conaco C, Xuan Z, et al. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci USA 2007; 104:19291-19296.
43. Ramkissoon SH, Mainwaring LA, Ogasawara Y, et al. He-matopoietic-specific microRNA expression in human cells. Leuk Res 2006; 30:643-647.